Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Gold

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
MLO: Medical Laboratory Observer|February 4, 2003
Driving forces in cancer diagnosticsTodd R Gander, Edward N Brody, Robert E Mehler, et al.
Molecular Therapy. Nucleic Acids|October 8, 2014
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsJohn C Rohloff, Amy D Gelinas, Thale C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2020
Modified nucleotides may have enhanced early RNA catalysisSteven K Wolk, Wesley S Mayfield, Amy D Gelinas, et al.
Advances in Experimental Medicine and Biology|February 14, 2013
Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeuticsMichael R Mehan, Rachel Ostroff, Sheri K Wilcox, et al.
ACS Sensors|June 10, 2023
Magnetically Detected Protein Binding Using Spin-Labeled Slow Off-Rate Modified AptamersShutian Lu, Catherine R Fowler, Brian Ream, et al.
Plos One|October 25, 2011
From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assayStephan Kraemer, Jonathan D Vaught, Christopher Bock, et al.
Plos One|April 18, 2012
Protein signature of lung cancer tissuesMichael R Mehan, Deborah Ayers, Derek Thirstrup, et al.
Journal of Proteome Research|July 22, 2024
Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the ProteomeStephan Kraemer, Daniel J Schneider, Clare Paterson, et al.
Plos One|December 21, 2010
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerRachel M Ostroff, William L Bigbee, Wilbur Franklin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsDouglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
MLO: Medical Laboratory Observer|February 4, 2003
Driving forces in cancer diagnosticsTodd R Gander, Edward N Brody, Robert E Mehler, et al.
Molecular Therapy. Nucleic Acids|October 8, 2014
Nucleic Acid Ligands With Protein-like Side Chains: Modified Aptamers and Their Use as Diagnostic and Therapeutic AgentsJohn C Rohloff, Amy D Gelinas, Thale C Jarvis, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 2, 2020
Modified nucleotides may have enhanced early RNA catalysisSteven K Wolk, Wesley S Mayfield, Amy D Gelinas, et al.
Advances in Experimental Medicine and Biology|February 14, 2013
Highly multiplexed proteomic platform for biomarker discovery, diagnostics, and therapeuticsMichael R Mehan, Rachel Ostroff, Sheri K Wilcox, et al.
ACS Sensors|June 10, 2023
Magnetically Detected Protein Binding Using Spin-Labeled Slow Off-Rate Modified AptamersShutian Lu, Catherine R Fowler, Brian Ream, et al.
Plos One|October 25, 2011
From SOMAmer-based biomarker discovery to diagnostic and clinical applications: a SOMAmer-based, streamlined multiplex proteomic assayStephan Kraemer, Jonathan D Vaught, Christopher Bock, et al.
Plos One|April 18, 2012
Protein signature of lung cancer tissuesMichael R Mehan, Deborah Ayers, Derek Thirstrup, et al.
Journal of Proteome Research|July 22, 2024
Crossing the Halfway Point: Aptamer-Based, Highly Multiplexed Assay for the Assessment of the ProteomeStephan Kraemer, Daniel J Schneider, Clare Paterson, et al.
Plos One|December 21, 2010
Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancerRachel M Ostroff, William L Bigbee, Wilbur Franklin, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 10, 2012
Unique motifs and hydrophobic interactions shape the binding of modified DNA ligands to protein targetsDouglas R Davies, Amy D Gelinas, Chi Zhang, et al.
Pageof 4